CP

CAROLINE POWERS

Not currently registered

At a glance

Status
Inactive
last filed Apr 2025
Clients
0
past 12 months
Filings
0
0 agencies · past 12 months
Activity
filings by quarter

Background

Career
Boston, MA
2024 - present

Specific issues

Funding related to biomedical and cancer research and innovation at the NIH and NCI, funding for Childhood Cancer research, funding for ARPA-H in the Labor, Health and Human Services, Education bill; funding for cancer prevention and smoking cessation programs at the CDC.
Budget/Appropriations · 2025 Q1
Issues related to health care access and reimbursement through the Medicare and Medicaid programs including site neutrality and prior authorization policies in the Medicare and Medicare Advantage program
Medicare/Medicaid · 2025 Q1
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Health Issues · 2025 Q1
Support for FDA's role to vigorously enforce the Family Smoking Prevention and Tobacco Control Act including the regulation of flavors, menthol and small cigars. Support for continued funding for the CDCs Office on Smoking and Health.
Tobacco · 2025 Q1
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Medical/Disease Research/Clinical Labs · 2025 Q1
Issues related to health care access and reimbursement through the Medicare and Medicaid programs including site neutrality and prior authorization policies in the Medicare program, specifically, The PATIENT Act of 2023 (H.R. 3561),the Healthcare Price Transparency Act (H.R. 4822), Accelerating Kids Access to Care Act(HR 3089, S 1544) and The Medicare Patient Access to Cancer Treatment (MPACT) Act (H.R. 4473).
Medicare/Medicaid · 2024 Q4

Clients

No client work disclosed in the past 12 months.

Past clients1
2024-2025 · 8 filings
$██,███ / qtrUnlock

Filings · past 12 months

Nothing filed in the past 12 months.

Older filings8
2025 Q1
DANA-FARBER CANCER INSTITUTE
Q1lda.gov →
2024 Q4
DANA-FARBER CANCER INSTITUTE
Q4lda.gov →
2024 Q1
DANA-FARBER CANCER INSTITUTE
1Alda.gov →
2024 Q2
DANA-FARBER CANCER INSTITUTE
2Alda.gov →
2024 Q3
DANA-FARBER CANCER INSTITUTE
3Alda.gov →
2024 Q3
DANA-FARBER CANCER INSTITUTE
Q3lda.gov →
2024 Q2
DANA-FARBER CANCER INSTITUTE
Q2lda.gov →
2024 Q1
DANA-FARBER CANCER INSTITUTE
Q1lda.gov →
Full record on lda.gov